Michael Schmidt
Stock Analyst at Guggenheim
(4.94)
# 33
Out of 5,116 analysts
120
Total ratings
72.63%
Success rate
55.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Maintains: Buy | $25 → $35 | $21.71 | +61.22% | 4 | Dec 16, 2025 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $12 | $5.40 | +122.22% | 1 | Nov 7, 2025 | |
| INCY Incyte | Upgrades: Buy | $125 | $100.11 | +24.86% | 7 | Nov 3, 2025 | |
| GMAB Genmab | Upgrades: Buy | $43 | $33.42 | +28.67% | 3 | Sep 23, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $125 → $30 | $29.08 | +3.18% | 4 | Aug 14, 2025 | |
| ADCT ADC Therapeutics | Reiterates: Buy | $10 | $3.51 | +184.90% | 6 | Aug 13, 2025 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $18 | $8.25 | +118.18% | 6 | Aug 13, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $10 → $12 | $5.17 | +132.11% | 5 | Aug 12, 2025 | |
| ONC BeOne Medicines AG | Maintains: Buy | $350 → $365 | $312.39 | +16.84% | 4 | Aug 7, 2025 | |
| ARVN Arvinas | Maintains: Buy | $16 → $15 | $12.16 | +23.36% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $10 | $8.67 | +15.34% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $38.88 | -56.28% | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $80.75 | -0.93% | 4 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $21.97 | +104.82% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $15 | $23.03 | -34.87% | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $52 | $81.32 | -36.06% | 1 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $8.56 | +16.82% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $21.30 | +50.23% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $23.04 | -65.28% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $96.92 | +12.46% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $8.06 | +73.70% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $22.53 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $46.24 | -9.17% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.09 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.55 | +260.36% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.36 | +488.24% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $36.13 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.52 | +1,246.15% | 4 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.33 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.73 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.38 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $15.22 | +123.39% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $3.48 | +618.39% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $17.29 | +73.51% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $6.59 | +294.84% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.75 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $28.02 | +185.51% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $10.23 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $4.78 | +15.06% | 2 | Nov 7, 2017 |
Immunome
Dec 16, 2025
Maintains: Buy
Price Target: $25 → $35
Current: $21.71
Upside: +61.22%
Foghorn Therapeutics
Nov 7, 2025
Initiates: Buy
Price Target: $12
Current: $5.40
Upside: +122.22%
Incyte
Nov 3, 2025
Upgrades: Buy
Price Target: $125
Current: $100.11
Upside: +24.86%
Genmab
Sep 23, 2025
Upgrades: Buy
Price Target: $43
Current: $33.42
Upside: +28.67%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $125 → $30
Current: $29.08
Upside: +3.18%
ADC Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $3.51
Upside: +184.90%
ORIC Pharmaceuticals
Aug 13, 2025
Reiterates: Buy
Price Target: $18
Current: $8.25
Upside: +118.18%
Compass Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $5.17
Upside: +132.11%
BeOne Medicines AG
Aug 7, 2025
Maintains: Buy
Price Target: $350 → $365
Current: $312.39
Upside: +16.84%
Arvinas
Aug 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $12.16
Upside: +23.36%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $10
Current: $8.67
Upside: +15.34%
Jul 8, 2025
Reiterates: Buy
Price Target: $17
Current: $38.88
Upside: -56.28%
Jun 25, 2025
Reiterates: Buy
Price Target: $80
Current: $80.75
Upside: -0.93%
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $21.97
Upside: +104.82%
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $23.03
Upside: -34.87%
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $81.32
Upside: -36.06%
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $8.56
Upside: +16.82%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $21.30
Upside: +50.23%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $23.04
Upside: -65.28%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $96.92
Upside: +12.46%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $8.06
Upside: +73.70%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $22.53
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $46.24
Upside: -9.17%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.09
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $5.55
Upside: +260.36%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.36
Upside: +488.24%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $36.13
Upside: -
Sep 30, 2024
Upgrades: Buy
Price Target: $7
Current: $0.52
Upside: +1,246.15%
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.33
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.73
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.38
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $15.22
Upside: +123.39%
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $3.48
Upside: +618.39%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $17.29
Upside: +73.51%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $6.59
Upside: +294.84%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $4.75
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $28.02
Upside: +185.51%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $10.23
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $4.78
Upside: +15.06%